TY - JOUR
T1 - Reactive oxygen species (ROS)
T2 - Critical roles in breast tumor microenvironment
AU - Malla, Rama Rao
AU - Surepalli, Nagalakshmi
AU - Farran, Batoul
AU - Malhotra, Sanjay V.
AU - Nagaraju, Ganji Purnachandra
N1 - Publisher Copyright:
© 2021 Elsevier B.V.
PY - 2021/4
Y1 - 2021/4
N2 - Increases in Reactive oxygen species (ROS) have been reported in breast tumors and their surrounding tumor microenvironment (TME) cells. ROS are critical factors in breast TME as they ensure bidirectional communication among various components and mediate multi-faceted roles in tumor progression and metastasis. This paper presents a detailed and comprehensive review of the studies exploring ROS and various forms of oxidative stress in cancer progression, specifically breast cancer (BC), its microenvironment and associated cell types. The paper focuses on several diverse aspects of cellular and molecular biology of cancer, with pharmacological implications of phytochemicals in BC. We also describe the role of ROS in the genetic and epigenetic reprogramming of the TME, metastasis, and drug resistance as well as regulators of BC TME. Additionally, we discuss ROS-mediated TME therapy and the therapeutic conundrum of breast TME. These contributions could prompt the development of personalized anti-cancer drugs for the treatment of highly complex and aggressive BCs.
AB - Increases in Reactive oxygen species (ROS) have been reported in breast tumors and their surrounding tumor microenvironment (TME) cells. ROS are critical factors in breast TME as they ensure bidirectional communication among various components and mediate multi-faceted roles in tumor progression and metastasis. This paper presents a detailed and comprehensive review of the studies exploring ROS and various forms of oxidative stress in cancer progression, specifically breast cancer (BC), its microenvironment and associated cell types. The paper focuses on several diverse aspects of cellular and molecular biology of cancer, with pharmacological implications of phytochemicals in BC. We also describe the role of ROS in the genetic and epigenetic reprogramming of the TME, metastasis, and drug resistance as well as regulators of BC TME. Additionally, we discuss ROS-mediated TME therapy and the therapeutic conundrum of breast TME. These contributions could prompt the development of personalized anti-cancer drugs for the treatment of highly complex and aggressive BCs.
KW - Breast cancer
KW - Hypoxia
KW - Precision medicine
KW - ROS
KW - Tumor microenvironment
UR - http://www.scopus.com/inward/record.url?scp=85102832375&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102832375&partnerID=8YFLogxK
U2 - 10.1016/j.critrevonc.2021.103285
DO - 10.1016/j.critrevonc.2021.103285
M3 - Review article
C2 - 33716202
AN - SCOPUS:85102832375
SN - 1040-8428
VL - 160
JO - Critical Reviews in Oncology/Hematology
JF - Critical Reviews in Oncology/Hematology
M1 - 103285
ER -